Chronic Rhinosinusitis and genetics of bitter taste receptors
慢性鼻窦炎与苦味受体遗传学
基本信息
- 批准号:8850843
- 负责人:
- 金额:$ 43.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-01 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAgonistAllelesAnti-Bacterial AgentsBacteriaBrainBreathingCellsChemicalsClinicalComplexDataDetectionDiseaseEnvironmental ExposureEpithelialEquilibriumEtiologyExposure toFailureFrequenciesFunctional disorderGenderGenesGeneticGenetic PolymorphismGenetic Predisposition to DiseaseGenetic VariationGenotypeGoalsGram-Negative BacteriaHealthHumanIndividualIndividual DifferencesInfectionLigandsLinkMeasuresMedicalMicrobeMucociliary ClearanceMucosal ImmunityNatural ImmunityNitric OxideNoseOperative Surgical ProceduresOral cavityOutcomePathway interactionsPatientsPlayPredispositionPrevalenceProcessProductionPseudomonas aeruginosaPublishingRaceRespiratory Tract InfectionsRoleSentinelSeveritiesSeverity of illnessSignal TransductionSinusStructure of respiratory epitheliumSymptomsSystemTaste BudsTaste PerceptionTestingTherapeuticTissuesVariantantimicrobialbactericidebaseburden of illnesschronic rhinosinusitiscohortdefense responseenteric pathogengenetic varianthigh throughput screeninghomoserine lactonekillingsmicrobialpathogenprognosticquorum sensingreceptorrespiratoryresponsescreeningsuccess
项目摘要
DESCRIPTION (provided by applicant): We have recently demonstrated that the bitter taste receptor T2R38 is expressed in the upper airway and is activated by acyl-homoserine lactones (AHLs): quorum-sensing molecules secreted by Pseudomonas aeruginosa and other gram-negative bacteria. Furthermore, we found that T2R38 regulates human upper airway innate defenses through nitric oxide production, which stimulates mucociliary clearance and has direct antibacterial effects. Moreover, common polymorphisms of the TAS2R38 gene, correlating with taste sensitivity to the molecule PTC, are linked to significant differences in the ability of uppe respiratory cells to clear and kill bacteria in response to AHLs. Based on these results, our central hypothesis is that the bitter taste receptor T2R38 expressed in the upper respiratory epithelium constitutes a sentinel defense network for the detection and clearance of microbes and that genetic variation in T2R38 contributes to individual differences in airway defensive capabilities. To test this hypothesis, we will: (1) determine whether TAS2R38 genotype, PTC taste sensitivity, and allele-specific expression correlate with symptom severity, disease burden, and interventional outcomes of chronic rhinosinusitis (CRS), and whether TAS2R38 polymorphisims not activated by AHLs are overrepresented in a cohort of CRS patient, and (2) identify other micorbial products that activate the common genetic variants of TAS2R38. The goal of these aims is to determine the role the bitter taste receptor T2R38 plays in upper airway defense and how common polymorphisms of this receptor contribute to upper airway disease. Furthermore, we will determine whether bitter taste sensitivity can be used as an indicator for disease severity in patients with chronic rhinosinusitis, and whether pharmacologic manipulation of this pathway has therapeutic potential.
描述(由申请人提供):我们最近证明苦味受体T2R38在上呼吸道中表达,并被酰基高丝氨酸内酯(AHL)激活:酰基高丝氨酸内酯(AHL)是铜绿假单胞菌和其他革兰氏阴性细菌分泌的群体感应分子。 此外,我们发现T2R38通过一氧化氮的产生调节人类上呼吸道先天防御,一氧化氮刺激粘液纤毛清除并具有直接抗菌作用。 此外,TAS2R38 基因的常见多态性与对 PTC 分子的味觉敏感性相关,与上呼吸道细胞响应 AHL 清除和杀死细菌的能力的显着差异有关。 基于这些结果,我们的中心假设是,上呼吸道上皮表达的苦味受体T2R38构成了检测和清除微生物的哨兵防御网络,并且T2R38的遗传变异导致气道防御能力的个体差异。 为了检验这一假设,我们将:(1)确定 TAS2R38 基因型、PTC 味觉敏感性和等位基因特异性表达是否与慢性鼻窦炎 (CRS) 的症状严重程度、疾病负担和干预结果相关,以及 TAS2R38 多态性是否未被激活AHL 在 CRS 患者队列中的比例过高,并且 (2) 识别出其他激活 AHL 常见遗传变异的微生物产物TAS2R38。 这些目标的目的是确定苦味受体 T2R38 在上呼吸道防御中的作用以及该受体的常见多态性如何导致上呼吸道疾病。此外,我们将确定苦味敏感性是否可以用作慢性鼻窦炎患者疾病严重程度的指标,以及该途径的药理操作是否具有治疗潜力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Noam A Cohen其他文献
Noam A Cohen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Noam A Cohen', 18)}}的其他基金
Human coronavirus infection of the nasal epithelium
鼻上皮的人冠状病毒感染
- 批准号:
10708154 - 财政年份:2022
- 资助金额:
$ 43.35万 - 项目类别:
Human coronavirus infection of the nasal epithelium
鼻上皮的人冠状病毒感染
- 批准号:
10596044 - 财政年份:2022
- 资助金额:
$ 43.35万 - 项目类别:
COVID-19: Elucidating the Role of the NasalEpithelium in SARS-CoV-2 Infection, Transmission, and Prevention
COVID-19:阐明鼻上皮在 SARS-CoV-2 感染、传播和预防中的作用
- 批准号:
10156951 - 财政年份:2021
- 资助金额:
$ 43.35万 - 项目类别:
COVID-19: Elucidating the Role of the NasalEpithelium in SARS-CoV-2 Infection, Transmission, and Prevention
COVID-19:阐明鼻上皮在 SARS-CoV-2 感染、传播和预防中的作用
- 批准号:
10350632 - 财政年份:2021
- 资助金额:
$ 43.35万 - 项目类别:
COVID-19: Elucidating the Role of the NasalEpithelium in SARS-CoV-2 Infection, Transmission, and Prevention
COVID-19:阐明鼻上皮在 SARS-CoV-2 感染、传播和预防中的作用
- 批准号:
10762415 - 财政年份:2021
- 资助金额:
$ 43.35万 - 项目类别:
Taste Receptor Genetics, The Sinonasal Microbiome and Chronic Rhinosinusitis
味觉感受器遗传学、鼻腔微生物群和慢性鼻窦炎
- 批准号:
10295185 - 财政年份:2017
- 资助金额:
$ 43.35万 - 项目类别:
Taste Receptor Genetics, The Sinonasal Microbiome and Chronic Rhinosinusitis
味觉感受器遗传学、鼻腔微生物组和慢性鼻窦炎
- 批准号:
10060737 - 财政年份:2017
- 资助金额:
$ 43.35万 - 项目类别:
Chronic Rhinosinusitis and genetics of bitter taste receptors
慢性鼻窦炎与苦味受体遗传学
- 批准号:
9272384 - 财政年份:2014
- 资助金额:
$ 43.35万 - 项目类别:
Chronic Rhinosinusitis and genetics of bitter taste receptors
慢性鼻窦炎与苦味受体遗传学
- 批准号:
9062423 - 财政年份:2014
- 资助金额:
$ 43.35万 - 项目类别:
Chronic Rhinosinusitis and genetics of bitter taste receptors
慢性鼻窦炎与苦味受体遗传学
- 批准号:
8760814 - 财政年份:2014
- 资助金额:
$ 43.35万 - 项目类别:
相似国自然基金
FOXD1-SFRP2及其特异性激动剂在骨关节炎中的功能及作用机制探究
- 批准号:82372438
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
脂质纳米粒体内介导嵌合抗原受体-M1型巨噬细胞协同TLR激动剂治疗实体瘤的研究
- 批准号:82304418
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
新型IL2Rβγ激动剂逐级控释联合放疗对抗三阴性乳腺癌的作用及机制研究
- 批准号:82303819
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TRPV4/SKCa信号轴在AMPK激动剂抑制微小动脉舒张作用中的机制研究
- 批准号:82304584
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向STING激动剂和TREM2抑制剂增强PD-1抑制剂对胰腺癌的抗肿瘤作用研究
- 批准号:82303740
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 43.35万 - 项目类别:
Exploring the role of ER Beta in disease penetrance in individuals with Li-Fraumeni syndrome
探索 ER Beta 在 Li-Fraumeni 综合征个体疾病外显率中的作用
- 批准号:
10548896 - 财政年份:2022
- 资助金额:
$ 43.35万 - 项目类别:
The intersection of GLP-1, gut microbiota, and brain connectivity in prodromal Alzheimer’s disease
GLP-1、肠道微生物群和大脑连接在阿尔茨海默病前驱期的交叉作用
- 批准号:
10352498 - 财政年份:2022
- 资助金额:
$ 43.35万 - 项目类别:
Nonlipogenic ABCA1 inducers for ADRD - Supplement
ADRD 的非脂肪生成 ABCA1 诱导剂 - 补充品
- 批准号:
10832305 - 财政年份:2022
- 资助金额:
$ 43.35万 - 项目类别: